Literature DB >> 16264420

Like it or not, life-extension research extends beyond biogerontology.

Aubrey D N J de Grey.   

Abstract

Mesh：

Year:  2005        PMID： 16264420      PMCID： PMC1371043          DOI： 10.1038/sj.embor.7400565

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

Review 2.  The foreseeability of real anti-aging medicine: focusing the debate.

Authors:  Aubrey D N J de Grey
Journal:  Exp Gerontol       Date:  2003-09       Impact factor: 4.032

3.  Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

Review 4.  Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers.

Authors:  Aubrey D N J de Grey; F Charles Campbell; Inderjeet Dokal; Leslie J Fairbairn; Gerry J Graham; Colin A B Jahoda; Andrew C G Porterg
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

5.  Is human aging still mysterious enough to be left only to scientists?

Authors:  Aubrey D N J de Grey; John W Baynes; David Berd; Christopher B Heward; Graham Pawelec; Gregory Stock
Journal:  Bioessays       Date:  2002-07       Impact factor: 4.345
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.